Yahoo · Oct 28, 2026
Adamas Trust: Q3 Earnings Snapshot
NEW YORK (AP) — NEW YORK (AP) — Adamas Trust, Inc. (ADAM) on Wednesday reported a third-quarter loss of $159.
NASDAQ · ADAMZ
Financial Services · Financial - Mortgages
$16.54
Up+$0.39 (+2.41%)
Updated Nov 5, 2026, 7:04 AM
SID Score
2.9/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · ADAMZ
1M range · 0 trading sessions · Daily adjusted prices
ADAMZ does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning ADAMZ.
Company
Market Activity
Research & News
ADAMZ research
Company profile and research snapshot.
Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing, and managing mainly mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit-sensitive single-family and multi-family assets.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 30, 2026 | Keefe, Bruyette & Woods | Market Perform | — |
| Oct 29, 2026 | Jones Trading | Buy | — |
| Sep 17, 2026 | Jones Trading | Buy | — |
| Sep 14, 2026 | Jones Trading | Buy | — |
| Sep 11, 2026 | Jones Trading | Buy | — |
Generated Nov 4, 2026, 9:01 PM
Adamas Trust's Series G preferred shares gained 1.36% following the release of parent company Adamas Pharmaceuticals' Q3 2026 earnings call transcript. The modest upward movement suggests investors are cautiously optimistic about the underlying company's financial performance and operational developments.
Bottom line: Today's 1.36% gain in ADAMZ reflects modest investor confidence following Adamas' Q3 earnings call, though the neutral sentiment of the headline suggests limited surprises or major catalysts. Investors should focus on the sustainability of the 7.000% dividend and the underlying pharmaceutical company's ability to maintain profitability amid competitive pressures—key drivers for preferred stock performance going forward.
Yahoo · Oct 28, 2026
NEW YORK (AP) — NEW YORK (AP) — Adamas Trust, Inc. (ADAM) on Wednesday reported a third-quarter loss of $159.
ChartMill · Oct 21, 2026
ADAMZ preferred clears Navellier’s growth screen, but weak balance sheet and dividend coverage warrant caution despite strong earnings and cash flow.
ChartMill · Sep 29, 2026
ADAMAS TRUST (ADAMZ) clears all 8 Little Book growth rules with strong earnings and sales gains, but weak balance sheet scores raise risk.
Yahoo · Sep 22, 2026
This article first appeared on GuruFocus. Adamas Trust Inc (NASDAQ:ADAM) recently announced a total dividend of $0.30 per share, with the ex-dividend date set for Sept. 22, 2026. The distribution consists entirely of a $0.30 per share cash dividend, payable on Oct. 28, 2026.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning ADAMZ.